ISTA PHARMACEUTICALS INC Operating Cash Flow
ISTA PHARMACEUTICALS INC reported Operating Cash Flow of -$9.01 million for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2012-05-04
- ISTA PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2012-03-31 was -$9.01M.
- ISTA PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2011-12-31 was $19.79M, a 50.17% increase year-over-year.
- ISTA PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2011-09-30 was -$19.44M, a 228.35% decline year-over-year.
- ISTA PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2011-06-30 was -$698.00K.
- ISTA PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2011 was -$3.49M, a 112.41% decline from fiscal 2010.
- ISTA PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2010 was $28.10M, a 604.69% increase from fiscal 2009.
- ISTA PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2009 was $3.99M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2012-03-31 | -$9.01M 10-Q · filed 2012-05-04 | $10.78M derived: sum of 2 quarters · filed 2012-05-04 | -$8.66M derived: sum of 3 quarters · filed 2012-05-04 | -$9.36M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-12-31 | $19.79M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $348.00K derived: sum of 2 quarters · filed 2012-02-27 | -$350.00K derived: sum of 3 quarters · filed 2012-02-27 | -$3.49M 10-K · filed 2012-02-27 |
| 2011-09-30 | -$19.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | -$20.14M derived: sum of 2 quarters · filed 2011-11-07 | -$23.27M 10-Q · filed 2011-11-07 | -$10.10M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-06-30 | -$698.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01 | -$3.83M 10-Q · filed 2011-08-01 | $9.34M derived: sum of 3 quarters · filed 2012-05-04 | $24.49M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-03-31 | -$3.14M 10-Q · filed 2012-05-04 | $10.04M derived: sum of 2 quarters · filed 2012-05-04 | $25.18M derived: sum of 3 quarters · filed 2012-05-04 | |
| 2010-12-31 | $13.18M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $28.32M derived: sum of 2 quarters · filed 2012-02-27 | $28.10M 10-K · filed 2012-02-27 | |
| 2010-09-30 | $15.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $14.92M 10-Q · filed 2011-11-07 | ||
| 2010-06-30 | -$225.00K 10-Q · filed 2011-08-01 | |||
| 2009-12-31 | $3.99M 10-K · filed 2012-02-27 |